Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Transcatheter closure of postsurgical residual ventricular septal defects: Early and mid-term results
Catheterization and Cardiovascular Interventions, Volume 75, No. 2, Year 2010
Notification
URL copied to clipboard!
Description
Background: The incidence of residual ventricular septal defects (VSDs) after surgery is 5-25%. Redo surgery is associated with higher risks. Methods: Between January 2000 to December 2008, 170 patients underwent percutaneous VSD closure in our centre: 22(16M) of these had 23 closures for residual VSDs. Median age was 32.5 yrs (1.4-79). All patients had echocardiographic signs of left ventricle volume overload (Qp/Qs ≥ 1.5). Nine patients had previous VSD closure, 6 tetralogy of Fallot repair, and 7, other procedures. There were 15 muscular, 6 perimembranous and 2 apical VSDs. Results: Amplatzer VSD devices were used in all. Median VSD size was 8 mm (4.3-16). Median fluoroscopy time was 33 minutes (15-130). There were three adverse events: 1 ventricular fibrillation requiring DC cardioversion; 1 transient complete atrio-ventricular block reverting to sinus rhythm at 24-hours; one patient had transient atrial flutter during the procedure. All procedures were successful; no additional procedures were required. Trivial residual shunts were seen in 3 patients at follow-up. There were no late events. One patient experienced arrhythmic death 5-yrs after procedure. One patient was reoperated due to dehiscence of VSD patch 2-yrs after the second successful percutaneous closure. Conclusions: Transcatheter closure of postsurgical residual VSD is safe and efficacious management option and obviates the need for further surgery and by-pass. © 2009 Wiley-Liss, Inc.
Authors & Co-Authors
Dua, Jaspal S.
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Carminati, Mario
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Lucente, Mariella
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Piazza, Luciane
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Chessa, Massimo
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Negura, Diana
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Bussadori, Claudio
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Saliba, Zakhia S.
Lebanon, Beirut
Hôtel-dieu de France Hospital
Butera, Gianfranco F.
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Statistics
Citations: 29
Authors: 9
Affiliations: 2
Identifiers
Doi:
10.1002/ccd.22262
ISSN:
15221946
e-ISSN:
1522726X
Research Areas
Health System And Policy
Study Design
Cohort Study